SCHEMBL8429048

SCHEMBL8429048

CCOC(=O)[C@@](C(=C=O)c1ccccc1)(c1cccc(NC=NN)c1)N(N)S(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.36
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 8/20 0.32
ALDH1A1 P00352 4/20 0.32
POLB P06746 3/20 0.32
RAB9A P51151 2/20 0.32
PKM P14618 1/20 0.32
THRB P10828 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
LMNA P02545 2/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430856 0.92 CA1 (0.37) DHODHCA12CA1CA2CA9
SCHEMBL8430805 0.89 DHODH (0.33) DHODHCA12CA1CA2CA9
SCHEMBL8432891 0.89 DHODH (0.36) DHODHCA12CA1CA2CA9
SCHEMBL8428788 0.89 DHODH (0.36) DHODHCA12CA1CA2CA9
SCHEMBL8429290 0.88 CA1 (0.33) CA1CA2MAPTALDH1A1RAB9A
SCHEMBL8432619 0.86 TRPV4 (0.35) DHODHCA12CA1CA2CA9
SCHEMBL8431423 0.85 DHODH (0.34) DHODHCA12CA1CA2CA9
SCHEMBL8431037 0.84 DHODH (0.37) DHODHCA12CA1CA2CA9
SCHEMBL8431176 0.79 UBE2M (0.34) CA1CA2SMN1; SMN2ALDH1A1PKM
SCHEMBL8430880 0.78 CA1 (0.37) CA12CA1CA2CA9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed